Pharmanovia A/S: Financial statements 2022
CVR: 32287824
Source: annual report 2022, Danish Business Authority
01/04/2021 – 31/03/2022
Pharmanovia A/S (CVR 32287824) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 3,431,174 and a net result of DKK -21,600,385 compared with DKK -2,028,136 the year before. That is a decrease of 77.5% compared with the year before. Equity in the 2022 report amounted to DKK -6,490,695. The company had 18 employees in the financial year.
- Gross Profit
- DKK 3,431,174
- Profit/Loss
- DKK -21,600,385
- Equity
- DKK -6,490,695
- Total Assets
- DKK 76,094,417
- Employees
- 18
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 3.4M | -21.6M | -6.5M | 18 |
| 2021 | - | 15.2M | -2M | 15.1M | 15 |
| 2020 | - | 3.7M | -13.7M | 17.1M | 12 |
| 2019 | - | 10.6M | -5.9M | -19.9M | 12 |
| 2018 | - | 2.6M | -9.2M | -14M | 8 |
Official annual report
Keep an eye on Pharmanovia A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of March 29, 2022, Rishi Bhikhu has left the board of directors of Pharmanovia A/S.
About Pharmanovia A/S
Pharmanovia A/S is a Danish company of the type Aktieselskab based in København S, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Atnahs Pharma Nordics A/S and PHARMANOVIA A/S. The management consists of Christoph Michael Habereder. The board consists of Mohammad Muqtadir Samy (chair), Christoph Michael Habereder and Twan Johannes Anna Nouwen. The company is owned by Atnahs Pharma UK Limited. The company has 3 employees (2026). In 2026, the company reported a gross profit of EUR 11,734,813 and a net result of EUR 7,730,657 compared with DKK 3,839,334 the year before. Equity in the 2026 report amounted to EUR 15,820,601.